These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29335204)

  • 1. Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors.
    Gu X; Jiang Y; Qu Y; Chen J; Feng D; Li C; Yin X
    Eur J Med Chem; 2018 Feb; 145():379-388. PubMed ID: 29335204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potent P-glycoprotein inhibitors.
    Gu X; Ren Z; Tang X; Peng H; Zhao Q; Lai Y; Peng S; Zhang Y
    Eur J Med Chem; 2012 May; 51():137-44. PubMed ID: 22405646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of substituted dibenzo[c,e]azepine-5-ones as P-glycoprotein-mediated multidrug resistance reversal agents.
    Tang X; Gu X; Ren Z; Ma Y; Lai Y; Peng H; Peng S; Zhang Y
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2675-80. PubMed ID: 22450134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of alkoxyl biphenyl derivatives bearing dibenzo[c,e]azepine scaffold as potential dual inhibitors of P-glycoprotein and breast cancer resistance protein.
    Gu X; Tang X; Zhao Q; Peng H; Peng S; Zhang Y
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3419-21. PubMed ID: 24928398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors.
    Gu X; Ren Z; Tang X; Peng H; Ma Y; Lai Y; Peng S; Zhang Y
    Bioorg Med Chem; 2012 Apr; 20(8):2540-8. PubMed ID: 22429509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a bifendate derivative bearing a 6,7-dihydro-dibenzo[
    Qiu J; Chen W; Jiang Y; Chen J; Zhang Y; Gu X
    Medchemcomm; 2018 Nov; 9(11):1826-1830. PubMed ID: 30542532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
    Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
    Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of LBM-A5 derivatives as potent P-glycoprotein-mediated multidrug resistance inhibitors.
    Wu Y; Pan M; Dai Y; Liu B; Cui J; Shi W; Qiu Q; Huang W; Qian H
    Bioorg Med Chem; 2016 May; 24(10):2287-97. PubMed ID: 27073052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
    Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
    Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
    Kim MK; Kim Y; Choo H; Chong Y
    Bioorg Med Chem; 2017 Feb; 25(3):1219-1226. PubMed ID: 28043777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives.
    Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK
    Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
    Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
    Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifendate-chalcone hybrids: a new class of potential dual inhibitors of P-glycoprotein and breast cancer resistance protein.
    Gu X; Ren Z; Peng H; Peng S; Zhang Y
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):318-22. PubMed ID: 25446092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery to solve multidrug resistance: Design, synthesis, and biological evaluation of novel agents.
    Qiu Q; Shi W; Zhao S; Zhu Y; Ding Z; Zhou S; Kairuki M; Huang W; Qian H
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900127. PubMed ID: 31441108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and anticancer activities evaluation of novel 5H-dibenzo[b,e]azepine-6,11-dione derivatives containing 1,3,4-oxadiazole units.
    He X; Li XY; Liang JW; Cao C; Li S; Zhang TJ; Meng FH
    Bioorg Med Chem Lett; 2018 Mar; 28(5):847-852. PubMed ID: 29456106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
    Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.